Rallybio is a private drug discovery company. It has raised $145 million across 1 recorded round; the latest was a $145 million Series B in May 2020.
PMV mark · valuation
—
Oct 2026
Last round
Early Stage VC (Series B)
May 2020
Team — not yet on record
No current team members for Rallybio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Rallybio with a free account
- ·Watch Rallybio: the Monday email on marks, rounds and moves
